SCHEMBL2464375

SCHEMBL2464375

Cc1cccc(N(c2ccccc2)c2ccc3c(c2)C2(c4cc(N(c5ccccc5)c5cccc(C)c5)ccc4-3)c3cc(N(c4ccccc4)c4cccc(C)c4)ccc3-c3ccc(N(c4ccccc4)c4cccc(C)c4)cc32)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDK2 Q15119 4/20 0.38
▸ ALDH1A1 P00352 4/20 0.36
▸ CYP3A4 P08684 2/20 0.36
▸ CYP2C9 P11712 2/20 0.36
▸ CYP2C19 P33261 2/20 0.36
▸ MAPT P10636 2/20 0.36
▸ TDP1 Q9NUW8 2/20 0.36
▸ L3MBTL1 Q9Y468 2/20 0.36
▸ KDM4E B2RXH2 1/20 0.36
▸ CYP1A2 P05177 1/20 0.36
▸ CYP2D6 P10635 1/20 0.36
▸ RAB9A P51151 3/20 0.35
▸ NPC1 O15118 2/20 0.35
▸ JAK2 O60674 1/20 0.35
▸ HTT P42858 1/20 0.35
▸ PAX8 Q06710 1/20 0.35
▸ THRB P10828 1/20 0.35
▸ PKM P14618 1/20 0.35
▸ ACHE P22303 1/20 0.34
▸ NPSR1 Q6W5P4 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13021491 1.00 PDK2 (0.38) PDK2ALDH1A1CYP3A4CYP2C9CYP2C19
SCHEMBL2431947 0.95 PDK2 (0.41) PDK2ALDH1A1CYP3A4CYP2C9CYP2C19
SCHEMBL29512073 0.95 PDK2 (0.41) PDK2ALDH1A1CYP3A4CYP2C9CYP2C19
SCHEMBL29351177 0.95 PDK2 (0.41) PDK2ALDH1A1CYP3A4CYP2C9CYP2C19
SCHEMBL18906597 0.95 PDK2 (0.41) PDK2ALDH1A1CYP3A4CYP2C9CYP2C19
SCHEMBL15473730 0.95 PDK2 (0.41) PDK2ALDH1A1CYP3A4CYP2C9CYP2C19
SCHEMBL17070108 0.95 PDK2 (0.41) PDK2ALDH1A1CYP3A4CYP2C9CYP2C19
SCHEMBL15910171 0.95 ACHE (0.38) PDK2ALDH1A1TDP1RAB9ANPC1
SCHEMBL31324815 0.92 ICMT (0.36) PDK2ALDH1A1CYP3A4CYP2C9CYP2C19
SCHEMBL14518387 0.92 ICMT (0.36) PDK2ALDH1A1CYP3A4CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 61 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2220702-B1 DEVICE COMPRISING AN ORGANIC COMPONENT AND AN ENCAPSULATION LAYER WITH A MOISTURE-REACTIVE MATERIAL COMMISSARIAT ENERGIE ATOMIQUE (FR) 2011-09-28 — — EP claimed
US-10355236-B2 Transparent electrode and electronic device Konica Minolta, Inc. (JP) 2019-07-16 — — US disclosed
US-9966557-B2 Translucent electrode, and electronic device Konica Minolta, Inc. (JP) 2018-05-08 — — US disclosed
US-9966557-B2 Translucent electrode, and electronic device Konica Minolta, Inc. (JP) 2018-05-08 — — US disclosed
US-9947889-B2 Transparent electrode, electronic device, and organic electroluminescent element KONICA MINOLTA INC. (JP) 2018-04-17 — — US disclosed
US-9947889-B2 Transparent electrode, electronic device, and organic electroluminescent element KONICA MINOLTA INC. (JP) 2018-04-17 — — US disclosed
US-9923166-B2 Transparent electrode and electronic device Konica Minolta, Inc. (JP) 2018-03-20 — — US disclosed
US-9923166-B2 Transparent electrode and electronic device Konica Minolta, Inc. (JP) 2018-03-20 — — US disclosed
US-9876189-B2 Transparent electrode, electronic device, and transparent electrode manufacturing method Konica Minolta, Inc. (JP) 2018-01-23 — — US disclosed
US-9876189-B2 Transparent electrode, electronic device, and transparent electrode manufacturing method Konica Minolta, Inc. (JP) 2018-01-23 — — US disclosed
US-8053024-B2 Method for manufacturing organic electroluminescent device KONICA MINOLTA HOLDINGS, INC. (JP) 2011-11-08 — — US disclosed
US-8053024-B2 Method for manufacturing organic electroluminescent device KONICA MINOLTA HOLDINGS, INC. (JP) 2011-11-08 — — US disclosed
EP-2220702-B1 DEVICE COMPRISING AN ORGANIC COMPONENT AND AN ENCAPSULATION LAYER WITH A MOISTURE-REACTIVE MATERIAL COMMISSARIAT ENERGIE ATOMIQUE (FR) 2011-09-28 — — EP disclosed
US-7939184-B2 Amine compounds, their preparation processes and the organic electroluminescent devices using the same E-RAY OPTOELECTRONICS TECHNOLOGY CO., LTD. (TW) 2011-05-10 — — US disclosed
US-7939184-B2 Amine compounds, their preparation processes and the organic electroluminescent devices using the same E-RAY OPTOELECTRONICS TECHNOLOGY CO., LTD. (TW) 2011-05-10 — — US disclosed
US-20100276818-A1 DEVICE COMPRISING AN ORGANIC COMPONENT AND AN ENCAPSULATION LAYER WITH A MOISTURE-REACTIVE MATERIAL COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) 2010-11-04 — — US disclosed
US-20090081357-A1 METHOD FOR MANUFACTURING ORGANIC ELECTROLUMINESCENT DEVICE KONICA MINOLTA HOLDINGS, INC. (JP) 2009-03-26 — — US disclosed
US-20090081357-A1 METHOD FOR MANUFACTURING ORGANIC ELECTROLUMINESCENT DEVICE KONICA MINOLTA HOLDINGS, INC. (JP) 2009-03-26 — — US disclosed
US-20080038587-A1 Novel amine compounds, their preparation processes and the organic electroluminescent devices using the same E-RAY OPTOELECTRONICS TECHNOLOGY CO., LTD. (TW) 2008-02-14 — — US disclosed
US-20080038587-A1 Novel amine compounds, their preparation processes and the organic electroluminescent devices using the same E-RAY OPTOELECTRONICS TECHNOLOGY CO., LTD. (TW) 2008-02-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080038587-A1 Novel amine compounds, their preparation processes and the organic electroluminescent devices using the same AOC2, AOC3, RPS4Y1 PDK2 1559/4885ALDH1A1 670/4885CYP3A4 944/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback